Arcutis Biotherapeutics, Inc. revenue for the last year amounted to 59.61 M USD, the most of which — 59.61 M USD — came from its highest performing source at the moment, Dermatological Treatments, the year earlier bringing 3.69 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Arcutis Biotherapeutics, Inc. 59.61 M USD, and the year before that — 3.69 M USD.